Mahaffey, K. W. Et Al. 2024. Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial. EUROPEAN HEART JOURNAL .

Mahaffey, K. W., Tuttle, K. R., ARICI, M., Baeres, F. M. M., Bakris, G., Charytan, D. M., ... Cherney, D. Z.(2024). Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial. EUROPEAN HEART JOURNAL .

Mahaffey, Kenneth Et Al. "Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial," EUROPEAN HEART JOURNAL , 2024

Mahaffey, Kenneth W. Et Al. "Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial." EUROPEAN HEART JOURNAL , 2024

Mahaffey, K. W. Et Al. (2024) . "Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial." EUROPEAN HEART JOURNAL .

@article{article, author={Kenneth W. Mahaffey Et Al. }, title={Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial}, journal={EUROPEAN HEART JOURNAL}, year=2024}